Board summary
Key figures
29,805
Registered population
61.7% aged 18–64
17.4%
Aged 65+
ICB 20.0% · England 17.9%
5.7%
Ethnic minority (non-White)
3.0% Asian · England 9.6%
44.6%
In IMD quintile 1
ICB 30.6% · England 21.0%
~11,722
Core20 residents (est.)
Resident basis; registered basis ~13,856 · see page 3
5,268
Hypertension register
+9.93% in 3 yrs · England +5.60%
436
SMI register
14.3% of Blackpool (LAD)'s
1,003
COPD register
Reviews -16.64% in 3 yrs
Forecast to 2030
6,446
Hypertension patients, 2030
+1,178 on today
71.9%
QRISK ≥20% on statins, 2030
+4.47pp over 3 yrs
4.9%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma review coverage trails England and fell sharply.
Asthma reviews sit at 48.8% (England 65.7%) after a -26.3% change (England +4.4%), leaving 1,159 unreviewed patients, which may reflect recall capacity.
Hypertension treatment to target improved faster than England.
Hypertension treatment to target grew +8.2% over 2023 to 2025 (England +3.6%; Blackpool (LAD) +1.6%), though current achievement is 66.3% (England 70.3%).
Population, age and ethnicity
Registered patients aged 65+ are 17.4%, below Blackpool (LAD) 20.4% and England 17.9%
Across three practices, Blackpool Central PCN registers 29,805 patients with a younger age profile than the surrounding area. Registered patients aged 65+ represent 17.4% (Blackpool (LAD) 20.4%, ICB 20.0%, England 17.9%), while children aged 0-17 make up 20.9% (Blackpool (LAD) 18.4%, ICB 19.6%, England 19.6%). Projected list growth to 2030 is 0.7% using an unverified methodology (Blackpool (LAD) 0.3%, ICB 1.7%, England 2.3%). Based on Census usual residents rather than registered patients, 94.3% are White (Blackpool (LAD) 94.7%, ICB 87.8%, England 81.1%), leaving a 5.7% ethnic minority share.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackpool (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackpool LA) | 1,647 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 77.1% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 53.2% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackpool LA) | 955 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackpool LA) | 16.9 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 share is 44.6% PCN-wide but spans 34.7 pp across member practices
The PCN Core20 share is 44.6%, though the weighted practice share is 46.5%, below Blackpool (LAD) at 55.1% but above NHS Lancashire and South Cumbria Integrated Care Board (30.6%) and England (21.0%). Across practices, shares span 34.7 pp: Layton Medical Centre has 69.11% (5,700 estimated patients), Marton Medical Practice has 42.29% (3,935 estimated patients), and Newton Drive Health Centre has 34.45% (4,221 estimated patients). Service planning must address both high deprivation concentration and large absolute patient volume across practices.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
436
SMI register
1.45% recorded prevalence
115
Learning disability register
0.38% recorded prevalence
20
Care homes, 601 beds
In the PCN catchment
10.9%
Provide unpaid care
Blackpool (LAD), Census 2021
The PCN registers 436 severe mental illness patients (1.4% vs Blackpool (LAD) 1.7%, ICB 1.2%, England 1.0%) and 115 learning disability patients (0.4% vs 0.6% across Blackpool (LAD), ICB, and England), alongside 20 catchment care homes containing 601 beds. Severe mental illness prevalence exceeds the England benchmark, representing a larger registered cohort (436 patients) than learning disability (115 patients).
Severe mental illness: physical health checks
Across 436 SMI patients (1.4%), recorded BP checks are 73.2% (England 83.4%; Blackpool (LAD) 76.0%) and BMI recording is 66.8% (England 82.1%). Lower completion may reflect unrecorded partial checks, which local audit would test.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,268
Hypertension register
+9.93%
Register growth, 3 yrs
Blackpool (LAD) +5.85% · England +5.60%
+5.14pp
BP control, under 80
≤140/90 · +2.99pp aged 80+
+1,178
More patients by 2030
Forecast 6,446 (21.23%)
Hypertension case-finding and control
The hypertension register records 5,268 patients (17.6% prevalence), above England (15.2%) and NHS Lancashire and South Cumbria Integrated Care Board (17.2%) but below Blackpool (LAD) (19.4%), following a 3-year change of +9.9% (England +5.6%). Recent blood pressure checks reach 86.8% (England 90.0%). Blood pressure control under age 80 is 63.7% (England 67.8%), spanning from 59.1% at Layton Medical Centre and 59.3% at Marton Medical Practice to 69.9% at Newton Drive Health Centre, while control for ages 80 and over is 76.0% (England 81.2%). Blood pressure control trails national benchmarks across both age bands.
Lipids and statins
Among patients with QRISK at or above 20%, 61.9% receive lipid-lowering therapy (England 63.6%; Blackpool (LAD) 62.5%), while diabetes statin coverage without cardiovascular disease is 70.7% (England 73.2%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 63,228 | £1.60 | £1.64 | £1.86 | £101,165 |
| Cardiovascular (all), 2025 | 98,573 | £2.98 | £3.38 | £3.33 | £293,748 |
In 2026, 63,228 lipid-regulating items were prescribed at £1.60 per item (England £1.86; Blackpool (LAD) £1.49; NHS Lancashire and South Cumbria Integrated Care Board £1.64), spending £16,439 less than at England's unit cost across 63,228 items.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−26.28%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+0.53%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 8.1% (2,264 patients; England 6.6%), but 12-month reviews fell 26.3% over three years (England +4.4%) to 48.8% (England 65.7%), leaving 1,159 patients unreviewed. COPD prevalence is 3.4% (1,003 patients), yet reviews dropped 16.6% over three years (England +2.8%) to 61.7% (England 76.4%). Reviews fall to 35.0% for asthma and 43.8% for COPD at Newton Drive Health Centre. Lower review coverage could reflect recall capacity pressures, which local clinical workflow audits would test.
Cancer register and children's immunisation
Cancer register prevalence is 3.9% (1,159 patients; England 3.8%). In childhood immunisation, 6-in-1 coverage at 12 months is 95.4% and age-five MMR1 is 97.2%, both exceeding the 95.0% target. However, age-five MMR2 is 91.5% (a 5.7 pp gap behind MMR1) and 4-in-1 booster coverage is 91.5%, both below the 95.0% target by 3.5 pp. Lower pre-school booster coverage could reflect scheduling friction, which local audit would test.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of staged cancers (4,642 of 8,863) were detected at stage 1 or 2, which trails England (55.3%) and is 22.6 pp below the 75.0% national ambition by 2028. Staging was known for 74.6% of registered cancers (8,863 of 11,883; England 67.0%). These system figures provide regional context rather than PCN performance. Locally, PCN screening uptake trails national benchmarks: cervical screening coverage aged 25-49 is 63.1% (England 66.8%), falling to 59.4% at Layton Medical Centre, while breast screening aged 53-70 is 65.7% (England 69.9%). Uptake gaps could reflect access barriers that targeted practice recall audits would test.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the 62-day referral to treatment standard, 17.5 pp below the 85.0% standard (Lancashire Teaching Hospitals NHS Foundation Trust 75.0%; University Hospitals of Morecambe Bay NHS Foundation Trust 72.4%; ICB 73.6%; England 71.2%). Its 28-day faster diagnosis rate reached 71.4% against the 75.0% standard (ICB 78.4%; England 79.3%), while 31-day treatment was 98.0% (standard 96.0%). For all diagnostic tests, 26.5% waited 6+ weeks at the trust (England 23.1%). These provider figures describe acute pathway pressure, not PCN referral performance.
| Pathways within standard (%) | Blackpool | Lancashire | of Morecambe Bay | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.38 | 82.90 | 78.39 | 78.39 | 79.32 |
| 31-day treatment (96%) | 97.96 | 89.43 | 95.22 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 67.48 | 75.04 | 72.35 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Blackpool | Lancashire | of Morecambe Bay | England |
|---|---|---|---|---|
| MRI | 21.80 | 2.41 | 4.04 | 21.40 |
| CT | 16.49 | 14.97 | 13.76 | 9.92 |
| Echocardiography | 7.57 | 13.85 | 10.55 | 28.48 |
| Colonoscopy | 13.08 | 0.00 | 0.60 | 30.83 |
| Gastroscopy | 12.47 | 0.00 | 1.45 | 29.02 |
| All 15 DM01 tests | 26.54 | 26.65 | 10.44 | 23.14 |
| Community services activity | Blackpool residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 28,770 | 193,720 |
| Referrals | 4,700 | 29,855 |
| Patients with a contact | 8,925 | 65,335 |
Community services (residents of Blackpool), Jun 2026 (provisional). In June 2026 (provisional experimental data), submitting providers recorded 3,335 community care activities for Blackpool local authority residents, within 533,345 activities reported across NHS Lancashire and South Cumbria ICB. Among contacts with Blackpool residents, adults aged 65+ accounted for 58.1% of activity (16,710 of 28,770). These experimental data describe local resident utilization across reporting providers and cannot be attributed to registered PCN patients.
Practice variation and patient experience
GP Patient Survey phone ease spans 22.1 pp across the three practices
In 2025/26, clinical QOF achievement reached 99.1% at Layton Medical Centre, 99.9% at Marton Medical Practice, and 100.0% at Newton Drive Health Centre (England 97.1%). Vaccination achievement spans 18.4 pp, from 47.1% at Marton Medical Practice to 65.5% at Layton Medical Centre. All-domain personalised care adjustments reached 18.3% at Layton Medical Centre against 10.0% nationally.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Newton Drive | 98 | 34.5 | 49.7% | 62.1% | 80.5% |
| Layton | 102 | 69.1 | 34.1% | 83.3% | 73.2% |
| Marton Medical | 113 | 42.3 | 56.3% | 70.6% | 71.0% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Thirteen of 25 trend measures trail England, led by falling respiratory reviews
Across 25 compared measures, 13 trail England's three-year change. The widest relative lags are in respiratory care: asthma reviews fell 26.3% (England +4.4%, trailing by 30.72 points), leaving current PCN review coverage at 48.8% (England 65.7%), while COPD reviews fell 16.6% (England +2.8%, trailing by 19.39 points) to 61.7% (England 76.4%). Conversely, relative gains outpaced England in blood pressure control under age 80 (+8.8% vs England +3.2%), diabetes HbA1c control (+9.6% vs England +4.4%), and hypertension treated to target (+8.2% vs England +3.6%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Asthma reviews
COPD reviews
Alcohol record (psychosis)
Diabetes statin (no CVD)
BMI record (SMI)
BP control, under 80
Diabetes HbA1c control
Hypertension treated to target
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackpool (LAD) | Asset | PCN | Blackpool (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 20 (601 beds) | n/a | Schools (catchment) | 55 | n/a |
| Children's centres | 6 | 13 | Places of worship | 30 | 62 |
| Libraries | 4 | 8 | Food banks (VCS) | 1 | 1 |
| Children and young people (VCS) | 1 | 1 | Primary schools (LA maintained) | 4 | 5 |
| Primary academies | 11 | 26 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review recall
Asthma 12-month review coverage is 48.8% across 2,264 patients (England 65.7%; Blackpool (LAD) 62.1%; ICB 65.0%; Newton Drive Health Centre 35.0%), leaving 1,159 unreviewed. For discussion: the PCN could run structured asthma recall using a single template, offering flexible appointments and reviewing inhaler prescribing alongside annual checks. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
SMI physical health check outreach
Across 436 SMI patients (1.4%), 12-month BP checks reach 73.2% (England 83.4%; Blackpool (LAD) 76.0%; Layton Medical Centre 63.4%) and BMI checks 66.8% (England 82.1%). For discussion: practices could audit partial check recording, offer combined physical health appointments or outreach slots, and raise shared recording pathways with system partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Learning disability register validation
Recorded learning disability prevalence is 0.4% (115 patients; 11.4% of borough register), below Blackpool (LAD), ICB, and England (all 0.6%), giving a +53 to +60 unadjusted gap. For discussion: practices could audit clinical records for uncoded learning disability diagnoses and explore cross-checking against local social-care records where data sharing permits. Low cost, quick to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Learning disability register review (p2) | Learning disability: QOF prevalence | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
| Targeted Core outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check audit (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension blood pressure recall audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool booster recall review (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Telephony and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN & Practice |
| Option 2 · SMI physical health check outreach (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
| Option 3 · Learning disability register validation (p12) | Learning disability register · Learning disability: QOF prevalence | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
